Alembic Pharmaceuticals consolidated net profit rises 14.60% in the June 2025 quarter
Sales rise 9.54% to Rs 1710.72 crore
Net profit of Alembic Pharmaceuticals rose 14.60% to Rs 154.38 crore in the quarter ended June 2025 as against Rs 134.71 crore during the previous quarter ended June 2024. Sales rose 9.54% to Rs 1710.72 crore in the quarter ended June 2025 as against Rs 1561.73 crore during the previous quarter ended June 2024. ParticularsQuarter EndedJun. 2025Jun. 2024% Var.Sales1710.721561.73 10 OPM %16.4215.16 -PBDT263.88226.07 17 PBT190.11157.03 21 NP154.38134.71 15Powered by Capital Market - Live News
Disclaimer: No Business Standard Journalist was involved in creation of this content
More From This Section
Don't miss the most important news and views of the day. Get them on our Telegram channel
First Published: Aug 05 2025 | 3:13 PM IST